27.06 17:51 | Aktien Schweiz mit leichten Abgaben |
27.06 07:20 | dpa-AFX: Roche Gets WHO Prequalification For Cobas HPV Test On Multiple Systems, Incl. Self-Collected Samples |
27.06 07:04 | dpa-AFX: *ROCHE EXPANDS ACCESS TO CERVICAL CANCER SCREENING TOOLS WITH TWO NEW WHO PREQUALIFICATION DESIGNATIONS |
27.06 07:00 | Press Release: Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection |
27.06 07:00 | Press Release: Roche expands access to cervical -2- |
26.06 17:48 | Aktien Schweiz erneut mit Abschlägen |
25.06 17:48 | Aktien Schweiz nach deutlichem Vortagesplus mit Abgaben |
25.06 07:48 | dpa-AFX: Roche's Ocrevus Subcutaneous Injection For Multiple Sclerosis Gets Approval In EU |
25.06 07:24 | Roche erhält EU-Zulassung für Multiple-Sklerose-Mittel |
25.06 07:11 | dpa-AFX: *ROCHE RECEIVES EU APPROVAL FOR OCREVUS SUBCUTANEOUS FOR MULTIPLE SCLEROSIS TREATMENT |
25.06 07:00 | Press Release: Roche's OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis |
25.06 07:00 | Press Release: Roche's OCREVUS subcutaneous -2- |
24.06 17:42 | Aktien Schweiz fest - Pharmawerte gesucht |
24.06 09:11 | dpa-AFX: Barclays belässt Roche auf 'Equal Weight' - Ziel 230 Franken |
24.06 07:00 | Press Release: Roche launches new analytical units for cobas(R) pro integrated solutions delivering greater efficiency and capacity to laboratories |
21.06 17:40 | Aktien Schweiz schließen schwächer |
21.06 03:45 | dpa-AFX: Sarepta Therapeutics' Elevidys Approved By FDA For Duchenne Muscular Dystrophy; Stock Surges |
20.06 18:59 | dpa-AFX: ANALYSE-FLASH: UBS belässt Roche auf 'Neutral' - Ziel 238 Franken |
20.06 18:59 | dpa-AFX: UBS belässt Roche auf 'Neutral' - Ziel 238 Franken |
20.06 17:53 | Aktien Schweiz freundlich - Zykliker und Finanzwerte gesucht |
|